Biomarkers

January 7, 2021January 7, 2021

$34M Funding Helps Speed Up New Class of Cancer Diagnostics

News

InterVenn Biosciences has raised $34 million to commercialize a new diagnostic tool for ovarian cancer, based on the identification of circulating proteins containing sugar molecules (glycoproteins). The company expects to ... Read more

June 23, 2020June 23, 2020

Protein Biomarkers to Gauge Cancer Response to Chemo Identified

News

Investigators using targeted proteomics — a technique to detect proteins of interest — on samples of ovarian cancer found a wide variety of biomarkers that might help predict which chemotherapies patients are more ... Read more

December 11, 2019

Cancer Research Teams Working to Identify Early Biomarkers of Ovarian Cancer

News

With a $544,360 developmental grant from the U.S. Department of Defense (DoD), four research teams are joining efforts to identify biomarkers of ovarian cancer with a goal of detecting the ... Read more

September 16, 2019

Collaborators Aim to Identify OC Patients Likely to Benefit from New Combo Therapy

News

The University of New Mexico (UNM) Comprehensive Cancer Center and the New Mexico Alliance for Cancer Care have entered a collaboration with Personalis to use its cancer immunogenomics platform to ... Read more

July 3, 2019

New Blood Test May Improve Ovarian Cancer Diagnosis, Study Suggests

News

A blood test that examines a panel of 11 specific proteins could help distinguish between benign tumors and malignant ovarian cancer, reducing the need for unnecessary surgeries and leading to ... Read more

March 25, 2019

Uterine Fluid Analysis May Aid in Early Diagnosis of Aggressive OC

News

Proteomic analysis — the characterization of all proteins present in a cell at a given time — in liquid biopsies from the womb may facilitate the early diagnosis of women ... Read more

March 2, 2018March 2, 2018

Scientists Discover Gene Variant that Could Help Predict Chemo Outcomes

News

Researchers have discovered new gene variants that affect how ovarian cancer patients respond to standard chemotherapy treatments Paraplatin (carboplatin) and Taxol (paclitaxel). The variants influence how a patient processes chemotherapy medications. ... Read more

June 2, 2017June 2, 2017

Blood Sugar and GLUT1 Protein May Be Biomarkers for Ovarian Cancer, Study Finds

News

Researchers studying blood glucose levels and the glucose transporter protein GLUT1 have discovered a potential biomarker for aggressive ovarian cancer. A study found that patients with lower blood glucose levels ... Read more

November 28, 2016

New InFlo Computer Method Predicts Cancer Cell Activity, Identifies Biomarkers

News

A new computed-based method called InFlo assesses cellular communication networks and identifies disease-specific network anomalies that can cause cancer and other diseases. This new tool may facilitate the discovery of ... Read more